For US residents only.

Pointing the Way Forward for You

Learn how TASIGNA can help treat Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML)

IMPORTANT SAFETY INFORMATION ABOUT TASIGNA® (nilotinib) Capsules:

QTc Prolongation and Sudden Death: TASIGNA can cause QTc prolongation, a possibly life-threatening heart problem. QTc prolongation causes an irregular heartbeat, which may lead to sudden death....

See More
Approved Uses:

TASIGNA® (nilotinib) capsules is a prescription medicine used to treat:

  • Adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
  • Adults with Ph+ CML in chronic phase and accelerated phase who no longer benefit from, or did not tolerate...
See More

Want to learn about TASIGNA?

See why TASIGNA® (nilotinib) capsules is an effective treatment for those who have been recently diagnosed with Ph+ CML in chronic phase.

Explore More

Switching to TASIGNA?

Get the facts on why some people with Ph+ CML in chronic phase are considering treatment with TASIGNA.

Learn More